Sera Prognostics, Inc.
SERA
Rank in Stocks
#20449
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on... Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
Share Price
$2.19
Last synced: 2026-11-09
Market Cap
$84.27M
Change (1 day)
0.00%
Change (1 year)
-18.59%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sera Prognostics, Inc. (SERA)
Category
Healthcare
Operating Margin for Sera Prognostics, Inc. (SERA)
Operating Margin as of November 2026 TTM: -53,282.86%
According to Sera Prognostics, Inc.'s latest financial reports, its current operating margin (TTM) is -53,282.86%. At the end of 2025 the company had an operating margin of -45,066.67%.
Operating Margin history for Sera Prognostics, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -53,282.86% | 18.23% |
| 2025 | -45,066.67% | -5.28% |
| 2024 | -47,577.92% | 265.61% |
| 2023 | -13,013.40% | -23.60% |
| 2022 | -17,034.33% | -60.54% |
| 2021 | -43,164.63% | -39.95% |
| 2020 | -71,884.00% | 56.12% |
| 2019 | -46,044.44% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -100.00% |
US
|
|
| 20.38% | -100.00% |
US
|
|
| 43.02% | -100.00% |
CN
|
|
| 32.03% | -100.00% |
US
|
|
| 22.23% | -100.00% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Sera Prognostics, Inc.'s operating margin
What is Sera Prognostics, Inc.'s operating margin?
Sera Prognostics, Inc.'s operating margin is -53,282.86%, as of Nov 2026.
What was Sera Prognostics, Inc.'s operating margin in 2025?
In 2025, Sera Prognostics, Inc.'s operating margin was -45,066.67%, compared with -47,577.92% in 2024.
How has Sera Prognostics, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Sera Prognostics, Inc.'s operating margin was highest in 2023 (-13,013.40%) and lowest in 2020 (-71,884.00%).
How does Sera Prognostics, Inc.'s operating margin compare with similar companies?
Sera Prognostics, Inc.'s operating margin (-53,282.86%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.